NTRK1 and Alzheimer disease: The LM11A-31-induced decrease in p75NTR levels may account, in part, for the reversal of cholinergic deficits by decreasing the abnormally high p75NTR/Trk ratio in the basal forebrain found in human AD and mouse models [25], [26], [47], [48].